Download PDF
Thromb Haemost 1990; 63(01): 146-147
DOI: 10.1055/s-0038-1645707
Letter to the Editor
Schattauer GmbH Stuttgart

Thrombotic Changes in Haemostasis Following Intravenous Streptokinase Treatment for Acute Myocardial Infarction

M Udvardy
2nd Department of Medicine, University Medical School, Debrecen, Hungary
,
J Hársfalvi
2nd Department of Medicine, University Medical School, Debrecen, Hungary
,
Z Boda
2nd Department of Medicine, University Medical School, Debrecen, Hungary
,
K Rak
2nd Department of Medicine, University Medical School, Debrecen, Hungary
› Author Affiliations
Further Information

Publication History

Received 23 August 1989

Accepted 27 October 1989

Publication Date:
02 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Simoons ML. Thrombolytic therapy in acute myocardial infarction. Ann Rev Med 1989; 40: 181-187
    CrossrefPubMedGoogle Scholar
  • 2 Bates ER, Topol EJ. Thrombolytic therapy for acute myocardial infarction. Chest 1989; (Suppl. 95) 257-263
    PubMedGoogle Scholar
  • 3 Jusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. I Treatment following myocardial infarction. J Am Med Assoc 1988; 260: 2089-2093
    PubMedGoogle Scholar
  • 4 Naylor CD, Armstrong PW. Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Can Med Assoc J 1989; 140: 1289-1299
    PubMedGoogle Scholar
  • 5 Hogg KJ. ECG evidence of myocardial salvage after thrombolysis in acute myocardial infarction. Br Heart J 1989; 61: 489-493
    CrossrefPubMedGoogle Scholar
  • 6 Rapaport SI. A plasma protein C activity assay suitable for clinical laboratory. Am J Clin Pathol 1989; 87: 491-497
    PubMedGoogle Scholar
  • 7 Zimmerman TS. Determination of the von Willebrand’s disease antigen in plasma by quantitative immunoelectrophoresis. J Lab Clin Med 1975; 86: 152-159
    PubMedGoogle Scholar
  • 8 Fitzgerald DJ, Wright F, FitzGerald GA. Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane-A2 modulate the response to tissue type plasminogen activator in vivo. Circulation Res 1989; 65: 83-94
    CrossrefPubMedGoogle Scholar